Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Investigation|September 22, 2012
Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progressionAndreas Weiss, Ulrike Träger, Edward J Wild, et al.
Molecular Cancer Therapeutics|March 18, 2014
ERBB3/HER2 signaling promotes resistance to EGFR blockade in head and neck and colorectal cancer modelsLi Zhang, Carla Castanaro, Bo Luan, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's DiseaseJohn Wityak, Michael E Prime, Frederick A Brookfield, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2019
A Biparatopic Antibody That Modulates MET Trafficking Exhibits Enhanced Efficacy Compared with Parental Antibodies in MET-Driven Tumor ModelsJohn O DaSilva, Katie Yang, Andres E Perez Bay, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's DiseaseMichael E Prime, Frederick A Brookfield, Stephen M Courtney, et al.
Plos One|March 27, 2019
Meso scale discovery-based assays for the detection of aggregated huntingtinWolfgang Reindl, Barbara Baldo, Jana Schulz, et al.
Pageof 8